Carsten Otto

1.5k total citations
31 papers, 950 citations indexed

About

Carsten Otto is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Carsten Otto has authored 31 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 11 papers in Cardiology and Cardiovascular Medicine and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Carsten Otto's work include Lipoproteins and Cardiovascular Health (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Blood properties and coagulation (8 papers). Carsten Otto is often cited by papers focused on Lipoproteins and Cardiovascular Health (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Blood properties and coagulation (8 papers). Carsten Otto collaborates with scholars based in Germany, Austria and Denmark. Carsten Otto's co-authors include Klaus G. Parhofer, P. Schwändt, H.C. Geiss, Klaus von Bergmann, H.C. Geiss, Werner Richter, Robert J. Frost, Ulrike Beisiegel, Hartmut Schmidt and Klaus Empen and has published in prestigious journals such as American Journal of Clinical Nutrition, The American Journal of Cardiology and Journal of Clinical Epidemiology.

In The Last Decade

Carsten Otto

30 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carsten Otto Germany	18	556	287	143	135	117	31	950
Emil M. deGoma United States	19	667 1.2×	425 1.5×	206 1.4×	365 2.7×	102 0.9×	40	1.4k
Therèse Heinonen Canada	19	691 1.2×	221 0.8×	242 1.7×	334 2.5×	32 0.3×	39	1.2k
Tomáš Štulc Czechia	16	567 1.0×	263 0.9×	258 1.8×	198 1.5×	89 0.8×	58	1.0k
Ping Qing China	20	654 1.2×	283 1.0×	112 0.8×	437 3.2×	111 0.9×	70	1.2k
Michael V. Holmes United Kingdom	16	361 0.6×	255 0.9×	234 1.6×	389 2.9×	77 0.7×	25	1.2k
José W.A. van der Hoorn Netherlands	21	662 1.2×	264 0.9×	357 2.5×	144 1.1×	139 1.2×	27	1.5k
Javier Navarro-Antolı́n Spain	12	402 0.7×	133 0.5×	295 2.1×	303 2.2×	296 2.5×	14	1.1k
Eiichi Geshi Japan	17	220 0.4×	174 0.6×	274 1.9×	383 2.8×	93 0.8×	65	885
Cristina Barale Italy	16	285 0.5×	131 0.5×	139 1.0×	213 1.6×	83 0.7×	33	722
Jianxin Lin United States	19	496 0.9×	207 0.7×	175 1.2×	178 1.3×	167 1.4×	67	1.7k

Countries citing papers authored by Carsten Otto

Since Specialization

Citations

This map shows the geographic impact of Carsten Otto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Otto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Otto more than expected).

Fields of papers citing papers by Carsten Otto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten Otto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Otto. The network helps show where Carsten Otto may publish in the future.

Co-authorship network of co-authors of Carsten Otto

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten Otto. A scholar is included among the top collaborators of Carsten Otto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten Otto. Carsten Otto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brockschmidt, Marc, et al.. (2012). Automated Termination Proofs for Java Bytecode with Cyclic Data. 1 indexed citations

Brockschmidt, Marc, Carsten Otto, & Jürgen Giesl. (2011). Modular Termination Proofs of Recursive Java Bytecode Programs by Term Rewriting. DROPS (Schloss Dagstuhl – Leibniz Center for Informatics). 10. 155–170. 10 indexed citations

Pusl, Thomas, Uli C. Broedl, Klaus G. Parhofer, & Carsten Otto. (2009). Long-term LDL apheresis does not stably improve hemorheology in hypercholesterolemic patients with coronary artery disease. Clinical Hemorheology and Microcirculation. 41(2). 137–142. 7 indexed citations

Otto, Carsten, et al.. (2007). Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia. Journal of Clinical Apheresis. 22(6). 301–305. 27 indexed citations

Geiss, H.C., Carsten Otto, & Klaus G. Parhofer. (2006). Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins. Metabolism. 55(5). 599–604. 25 indexed citations

Otto, Bärbel, Rudolf L. Riepl, Carsten Otto, et al.. (2005). µ‐Opiate receptor agonists – a new pharmacological approach to prevent motion sickness?. British Journal of Clinical Pharmacology. 61(1). 27–30. 16 indexed citations

Otto, Carsten, H.C. Geiss, Klaus Empen, & Klaus G. Parhofer. (2004). Long-term reduction of C-reactive protein concentration by regular LDL apheresis. Atherosclerosis. 174(1). 151–156. 34 indexed citations

Otto, Carsten, Peter Kern, Rolf Bambauer, et al.. (2003). Efficacy and Safety of a New Whole‐blood Low‐density Lipoprotein Apheresis System (Liposorber D) in Severe Hypercholesterolemia. Artificial Organs. 27(12). 1116–1122. 53 indexed citations

Parhofer, Klaus G., et al.. (2002). Effects of phytosterol ester-enriched margarine on plasma lipoproteins in mild to moderate hypercholesterolemia are related to basal cholesterol and fat intake. Metabolism. 51(2). 189–194. 89 indexed citations

10.

Empen, Klaus, et al.. (2002). The effects of three different LDL‐apheresis methods on the plasma concentrations of E‐selectin, VCAM‐1, and ICAM‐1. Journal of Clinical Apheresis. 17(1). 38–43. 40 indexed citations

11.

Otto, Carsten, et al.. (2002). Effects of Direct Adsorption of Lipoproteins Apheresis on Lipoproteins, Low‐Density Lipoprotein Subtypes, and Hemorheology in Hypercholesterolemic Patients with Coronary Artery Disease. Therapeutic Apheresis. 6(2). 130–135. 20 indexed citations

12.

Locatelli, S., Dieter Lütjohann, Hartmut Schmidt, et al.. (2002). Reduction of Plasma 24S-Hydroxycholesterol (Cerebrosterol) Levels Using High-Dosage Simvastatin in Patients With Hypercholesterolemia. Archives of Neurology. 59(2). 213–213. 133 indexed citations

13.

Geiss, H.C., Carsten Otto, P. Schwändt, & Klaus G. Parhofer. (2001). Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects. Metabolism. 50(8). 983–988. 34 indexed citations

14.

Frost, Robert J., Carsten Otto, H.C. Geiss, P. Schwändt, & Klaus G. Parhofer. (2001). Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia. The American Journal of Cardiology. 87(1). 44–48. 110 indexed citations

15.

Otto, Carsten, Michael M. Ritter, Werner Richter, Ralf Minkenberg, & P. Schwändt. (2001). Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks. Metabolism. 50(2). 166–170. 28 indexed citations

16.

Otto, Carsten, Werner Richter, & P. Schwändt. (2000). Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: Evaluation by selective depletion of low-density lipoproteins or fibrinogen. Metabolism. 49(6). 810–813. 23 indexed citations

17.

Otto, Carsten, H.C. Geiss, Markus G. Donner, Klaus G. Parhofer, & P. Schwändt. (2000). Influence of Atorvastatin Versus Simvastatin on Fibrinogen and Other Hemorheological Parameters in Patients with Severe Hypercholesterolemia Treated with Regular Low‐Density Lipoprotein Immunoadsorption Apheresis. Therapeutic Apheresis. 4(3). 244–248. 6 indexed citations

18.

Schwändt, P., H.C. Geiss, Michael M. Ritter, et al.. (1999). The Prevention Education Program (PEP). A Prospective Study of the Efficacy of Family-Oriented Life Style Modification in the Reduction of Cardiovascular Risk and Disease. Journal of Clinical Epidemiology. 52(8). 791–800. 43 indexed citations

19.

Otto, Carsten, et al.. (1997). Postprandial hemorrheology and apolipoprotein B metabolism in patients with familial hypertriglyceridemia. Metabolism. 46(11). 1299–1304. 9 indexed citations

20.

Otto, Carsten, et al.. (1996). Effects of n-3 fatty acids and fenofibrate on lipid and hemorrheological parameters in familial dysbetalipoproteinemia and familial hypertriglyceridemia. Metabolism. 45(10). 1305–1311. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact